Abstract
Anemia is the most common hematologic abnormality in patients with cancer. Anemia can be defined in several ways including: (1) decrease in red blood cell count, hemoglobin, or hematocrit (concentration measurements); (2) decrease in the red cell volume or Cr51 red cell mass. The mechanisms of cancer-related anemia are treated in detail in other reviews (1, 2).
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Bateman LJT, Beard MEJ. 1976. Malignant disease. In: Haematologic Aspects of Systemic Disease. Israel MCG, Delamore IW (eds). Saunders, London, pp 131–161.
Doll DC, Weiss RB. 1985. Neoplasia and the erythron. J Clin Oncol 3:429–446.
Eichner ER. 1979. Splenic function: Normal, too much and little. Am J Med 66:311–320.
Goldman JM, Nolasco I. 1983. The spleen in myeloproliferative disorders. Clin Haematol 12:505–516.
Christinsen BE, Jonsson V, Videback A. 1983. The spleen in lymphoproliferative disorders. Clin Haematol 12:517–533.
Lynch EC, Alfrey CP Jr. 1965. Histiocytic medullary reticulosis. Hemolytic anemia due to erythrophagocytosis by histiocytes. Ann Intern Med 63:666–671.
Jaffe ES, Costa I, Fauci AS et al. 1983. Malignant lymphoma and erythophagocytosis simulating malignant histiocytosis. Am J Med 75:741–749.
Scott RB, Robb Smith AHT. 1939. Histiocytic medullary reticulosis. Lancet 2:194–198.
Cartwright GE. 1966. The anemia of chronic disorders. Sem Hematol 3:351–373.
Cartweight GE, Lee GR. 1971. The anemia of chronic disease. Br J Haematol 21:147–152.
Hyman GA, Gelhorn A, Harray J. 1956. Studies of the anemia of disseminated malignant neoplastic disease. II. Study of the life span of the erythrocyte. Blood 11:618–631.
Douglas SW, Adamson JW. 1975. The anemia of chronic disorders: Studies of marrow regulation and iron metabolism. Blood 45:55–65.
Dumick N, Kalkami V, Howard D et al. 1983. Mechanisms of abnormal erythropoiesis in malignancy. Cancer 51:1101–1106.
Chanarin I. 1976. Investigation and management of megaloblastic anemia. Clin Haematol 5:747–763.
Krantz S. 1974. Pure red cell aplasia. N Engl J Med 291:345–350.
Krantz, S. 1976. Diagnosis and treatment of pure red cell aplasia. Med Clin North Am 60:945–958.
Hirst E, Robertson TE. 1967. The syndrome of thymoma and erythroblastopenic anemia — A review of 56 cases. Medicine 46:225–264.
Sieff C. 1983. Pure red cell aplasia. Br J Haematol 54:331–336.
Mitchell ABS, Pinn G, Pegrum GD. 1971. Pure red cell aplasia and carcinoma. Blood 37:594–597.
Slater LM, Schultz MJ, Armentrout SA. 1974. Remission of pure red cell aplasia associated with non thymic malignancy. Cancer 44:1879–1881.
Natelson EA, Lynch EC, Hettig RA, Alfrey CP. Jr. 1968. Histiocytic medullary reticulosis. Arch Intern Med 122:223–229.
Tseng A Jr, Coleman CN, Cox RS et al. 1984. The treatment of malignant histiocytosis. Blood 64:48–53.
Dacie JV. 1975. Autoimmune haemolytic anemia. Arch Intern Med 135:1293–1306.
Jones JE. 1973. Autoimmune disorders and malignant lymphoma. Cancer 31:1092–1098.
Worlledge SH. 1978. The interpretation of a positive direct antiglobulin test. Br J Haematol 38:157–162.
Sokol RJ, Hewitt S, Stamps BK. 1981. Autoimmune hemolytic anemia: An 18 year study of 865 cases referred to a regional transfusion center. Br Med J 282:2023–2027.
Kyle RA, Kiely JM, Stickney JM. 1959. Acquired hemolytic anemia in chronic lymphocytic leukemia and the lymphomas. Arch Intern Med 104:61–67.
Eisner E, Ley AB, Meyer K. 1967. Coombs-positive hemolytic anemia in Hodgkin’s disease. Ann Intern Med 66:258–273.
Levine AM, Thornton P, Forman SJ et al. 1980. Positive Coombs test in Hodgkin’s disease: Significance and implications. Blood 55:607–611.
Garraty G, Petz LD, Wallerstein RO, Fudenberg HH. 1974. Autoimmune hemolytic anemia in Hodgkin’s disease associated with anti-It. Transfusion 14:226–231.
Crisp D, Pruzanski W. 1982. B-cell neoplasms with homogenous cold-reacting antibodies (cold agglutinin). Am J Med 72:915–922.
Pruzanski W, Shumak KH 1977. Biologic activity of cold reacting autoantibodies. N Engl J Med 297:578–592.
Brain MC. 1970. Microangiopathic hemolytic anemia. Ann Rev Med 21:133–144.
Lohrmann HP, Adam W, Heymer B, Kubanek A. 1973. Microangiopathic hemolytic anemia in metastatic carcinoma. Ann Intern Med 79:368–375.
Brain MC. 1972. Microangiopathic hemolytic anemia. Br J Haematol 23:45–52.
Antman KH, Skarin AT, Mayer RJ, Hargraves HK, Canellos GP. 1979. Microangiopathic hemolytic anemia and cancer: A review. Medicine 58:377–384.
Alpert LI, Benisch B. 1970. Hemangioendothelioma of the liver associated with microangiopathic hemolytic anemia. Report of four cases. Am J Med 48:624–628.
Davis S, Rambotti P, Grignoni F. 1985. Microangiopathic hemolytic anemia and pulmonary small cell carcinoma. Ann Intern Med 103:638.
Cantrell JE, Phillips TM, Schein PS. 1985. Carcinoma-associated hemolytic anemia syndrome: A complication of Mitomycin C chemotherapy. J Clin Oncol 3:723–734.
Price TM, Murgo AJ, Keveney JJ et al. 1985. Renal failure and hemolytic anemia associated with Mitomycin C. A case report. Cancer 55:51–56.
Clifford GO. 1966. The clinical significance of leucoerythroblastic anemia. Med Clin North Am 50:789–799.
Ehmen L. 1976. Bone marrow biopsy in the evaluation of lymphoma, carcinoma and granulomatous disorders. Am J Med 60:1–7.
Valentine WN, Hennessey TC, Lang E et al. 1968. Polycythemia, erythrocytosis, and erythemia. Ann Intern Med 69:587–606.
Daman A, Holub DA, Medicow MM et al. 1958. Polycythemia and renal carcinoma: Report of ten new cases, two with long standing hematologic remission following nephrectomy. Am J Med 25:182–197.
Tso SC, Hua ASP. 1974. Erythrocytosis in hepatocellular carcinoma. Br J Haematol 28:497–503.
Waldmann TA, Levin EH, Baldwin M. 1961. The association of polycythemia with a cerebellar hemangioblastoma. The production of an erythropoietin stimulating factor by the tumor. Am J Med 31:318–324.
Lipsett MB, Odell WD, Rosenberg E, Waldmann TA. 1964. Numoral syndromes associated with nonendocrine tumors. Ann Intern Med 61:733.
Adamson JW, Finch CA. 1968. Erythropoietin and the polycythemias. Ann. NY Acad Sci 149:560–568.
Waldmann TA, Rosse WF, Swann RI. 1968. The erythropoietin-stimulating factors produced by tumors. Ann NY Acad Sci 149:509–515.
Hammond A, Winnick A. 1974. Paraneoplastic erythrocytosis and ectopic erythropoietin. Ann NY Acad Sci 230:219–227.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1986 Martinus Nijhoff Publishers, Boston
About this chapter
Cite this chapter
Davis, W.M. (1986). Hematologic disorders associated with cancer: I. Red blood cell disorders. In: Higby, D.J. (eds) Issues in Supportive Care of Cancer Patients. Cancer Treatment and Research, vol 30. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-2325-9_1
Download citation
DOI: https://doi.org/10.1007/978-1-4613-2325-9_1
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-9429-0
Online ISBN: 978-1-4613-2325-9
eBook Packages: Springer Book Archive